The complete list of substances being removed from Category 2 is as follows: BPC-157 Cathelicidin LL-37 Dihexa Acetate Emideltide (DSIP) Epitalon GHK-Cu (for injectable routes of administration) KPV Mechano Growth Factor, Pegylated (PEG-MGF) Melanotan II MOTs-C Semax (heptapeptide) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) Of these, the substances not scheduled for consideration at the upcoming meeting in July (Cathelicidin LL-37, Dihexa Acetate, GHK-Cu (injectable routes of administration), Mechano Growth Factor Pegylated (PEG-MGF), and Melanotan II) are slated for separate PCAC consultation before the end of February 2027
Previously, our winner in this category was Codeage, but with the company putting a temporary pause on subscriptions, its no longer the most convenient option
BPC-157 is a synthetic 15-amino-acid peptide derived from a protective protein in human gastric juice
On the other hand, the non-tumorigenic, spontaneously immortalized keratinocyte cell line - HaCaT cells can provide almost unlimited supply of identical cells, ensuring high intra- and inter-laboratory reproducibility
These tissues have limited natural cellularity, meaning fewer resident cells are available to perform repairs
The tenosynovium (tendon sheath) benefits from enhanced healing while the tendons themselves undergo repair and strengthening
